Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression
NCT02443844 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2015-05-14
Summary
The purpose of this study is to compare medical and surgical treatments of benign prostate hyperplasia in patients who have non muscle invasive bladder cancer for tumour recurrence and progression.
Conditions
Interventions
- PROCEDURE
-
Transurethral Resection
Endoscopic treatment of bladder cancer
- DRUG
-
Tamsulosin
Medical treatment for benign prostate hyperplasia
Sponsors & Collaborators
-
Diskapi Teaching and Research Hospital
lead OTHER
Principal Investigators
-
Nihat Karakoyunlu, MD · Dıskapı TRH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2018-02-28
- Completion
- 2020-02-29
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation
NCT05084586 ·Status: UNKNOWN ·Phase: NA
-
Effect of Tumor Base Size in Bladder Cancer
NCT06632340 ·Status: COMPLETED ·Phase: NA
-
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504 ·Status: RECRUITING
-
Prophylactic Intravesical Chemotherapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: a Randomized Controlled Trial Between Single Postoperative Dose Versus Maintenance Therapy.
NCT02438865 ·Status: COMPLETED ·Phase: PHASE2
-
Radical Cystectomy Versus Tri-Modal Therapy for Treatment of cT2N0M0 Urinary Bladder Transitional Cell Carcinoma
NCT07043790 ·Status: COMPLETED ·Phase: NA
-
Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade
NCT02992990 ·Status: UNKNOWN ·Phase: NA
-
Prophylactic Intravesical Chemotherapy to Prevent Bladder Tumors After Nephroureterectomy for Primary Upper Urinary Tract Urothelial Carcinomas
NCT02547350 ·Status: UNKNOWN ·Phase: PHASE2
-
Gemcitabine Hydrochloride, Cisplatin, and AGS-003-BLD in Treating Patients With Muscle-Invasive Bladder Cancer Undergoing Surgery
NCT02944357 ·Status: WITHDRAWN ·Phase: NA
-
En-Bloc Resection of Bladder Tumors
NCT04784507 ·Status: UNKNOWN ·Phase: PHASE2
-
Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent TURBK.
NCT06167356 ·Status: RECRUITING
-
Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer
NCT02494635 ·Status: TERMINATED
-
Intraoperative vs. Postoperative Intravesical Epirubicin Instillation for Prevention of Bladder Recurrence in High-Risk Upper Urinary Tract Urothelial Carcinoma
NCT06941038 ·Status: COMPLETED
-
sEphB4-HSA Before Surgery in Treating Patients With Bladder Cancer, Prostate Cancer, or Kidney Cancer
NCT02767921 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT04688931 ·Status: TERMINATED ·Phase: PHASE3
-
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy
NCT02145390 ·Status: TERMINATED ·Phase: NA
-
Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
NCT02716961 ·Status: UNKNOWN ·Phase: NA
-
Outcome of Treating Bladder Cancer in Sohag University Hospital
NCT05082818 ·Status: COMPLETED
-
Diagnostic Performance and Predictive Capacity of Immediate Urine Cytology After Transurethral Resection of Non-Muscle Invasive Bladder Cancer; A Prospective Study
NCT04194112 ·Status: COMPLETED ·Phase: NA
-
Intravesical Epirubicin Plus BCG to Prevent the Recurrence of Transitional Cell Carcinoma of Bladder
NCT00343356 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer That Was Removed by Surgery
NCT00777491 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer
NCT06074484 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
NCT05243550 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Value of Immediate Post-operative Intravesical Epirubicin in Intermediate&High Risk Non Muscle Invasive Bladder Cancer
NCT02214602 ·Status: COMPLETED ·Phase: PHASE4
-
Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma
NCT00461851 ·Status: COMPLETED ·Phase: PHASE2
-
Bladder Sparing Treatment of Tislelizumab, Gemcitabine and Cisplatin for Patients With PD-L1 Positive Muscle Invasive Bladder Cancer
NCT05401279 ·Status: UNKNOWN ·Phase: PHASE2